Home Stock Market Texas Instruments Stock Falls on Soft Guidance, Analysts Blame Restrictions in China By Investing.com

Texas Instruments Stock Falls on Soft Guidance, Analysts Blame Restrictions in China By Investing.com

0
Texas Instruments Stock Falls on Soft Guidance, Analysts Blame Restrictions in China By Investing.com

[ad_1]

© Reuters. Texas Instruments (TXN) Stock Falls on Soft Guidance, Analysts Blame Restrictions in China

Texas Instruments (NASDAQ:) issued a weaker-than-expected Q2 forecast, sending its shares tumbling more than 3% in premarket trading Wednesday.

The company reported revenue of $4.91 billion, up 14% YoY and above the analyst consensus of $4.72 billion. Strong sales were fueled by “growth in industrial and automotive.”

TXN reported Q2 EPS of $2.35, up from $1.87 in the year-ago period. The EPS print took into account a 2-cent benefit for items that were not included in the initial guidance.

Analog revenue stood at $3.82 billion, up 16% YoY, topping the consensus estimates of $3.67 billion. Embedded processing revenue came in at $782 million, up 2% YoY and compared to the estimated $769 million.

For Q2, the semiconductor maker expects revenue in the range of $4.2 billion to $4.8 billion, missing the consensus estimates of $4.96 billion.

TXN expects EPS in the range of $1.84 to $2.26, short of the estimated $2.28 per share.

“This outlook comprehends an impact due to reduced demand from COVID-19 restrictions in China,” the company said in a press release.

Barclays analyst Blayne Curtis lowered the price target to $150.00 per share from $170.00 and said TXN’s results should be seen as “merely the beginning of a broader cyclical correction.”

“The lower June guidance was a surprise, but we do expect increased shortages and shutdowns to be a bigger trend through earnings… We do see a substantial cycle coming and this reset as only the beginning of a larger correction. TXN history tells us that every DD growth year is usually followed by decline the year after, and after 27% growth in 2021, we view a sizable correction as needed. We do recognize that analog names are typically safer in a market correction but we still don’t believe the stock has corrected enough to become interesting,” Curtis said on the Underweight-rated TXN stock.

BofA analyst Vivek Arya lowered the price target to $190.00 per share from the prior $200.00 and is more bullish on TXN than his Barclays (LON:) colleague.

“We reiterate Buy on a strong track record of consistent share gains, free cash flow generation and returns, and profitability resilience even in a downcycle,” Curtis said in a note.

By Senad Karaahmetovic

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here